Cigarettes with ultralow nicotine levels are now being called the game-changer in the fight against smoking. If you are having trouble in quitting smoking, then, it is for you, that soon the Biden White House is expected to formally propose a plan that will order cigarette nicotine levels to be reduced, reports The Washington Post. For now though, it has been a failure, as these cigarettes, also known as VLN cigarettes that stands for very low nicotine are only available in 5,100 stores in 26 states. This is a very small fraction of the overall market for cigarettes. The company that makes it, 22nd Century, is struggling not because of the low supply, but also from the advocates who have long believed slashing nicotine levels altogether.
Nicotine is a chemical that is produced naturally from tobacco that makes the cigarette and also keeps people hooked. While it is believed that it makes people alert, and get the "hit" to keep them going, it exposes the users to harmful substances, carcinogens, and increases the risk of heart disease, lung cancer, and other illness.
Ultralow-nicotine cigarettes, like the VLN brand, contain about 95% less nicotine than the regular cigarettes. The idea is quite simple: without the addictive grip of nicotine, smokers will find it easier to quit. Research too has shown some promise. For instance, the studies funded by the National Institute on Drug Abuse revealed that very low nicotine cigarettes reduced addiction potential significantly without having users to increase their smoking frequency. However, the problem is, why would anyone choose for a low-nicotine that does not make them feel the same way, when the high-nicotine cigarette is right next to it, making them feel the same way, with the same alertness, sold at the same price.
“It’s very hard to imagine someone actively choosing to continue to use a low-nicotine product for the same price when a high-nicotine product is right next to it,” said Eric Donny, a Wake Forest University School of Medicine nicotine researcher.
No wonder, the experiment with low nicotine product by Philip Morris' Next cigarettes in the 1980s and Vector Tobacco's Quest brand in the early 2000s, flopped.
The Food and Drug Administration (FDA) has supported the development of such products, even allowing VLN cigarettes to be marketed as lower-risk options. However, these products remain a niche market, available in only a fraction of U.S. stores.
Recently, the Biden administration has considered a bold step—mandating a dramatic reduction in nicotine levels for all cigarettes sold in the United States. Supporters believe this move could save millions of lives, while critics, including tobacco companies, warn of potential unintended consequences.
Resistance from Big Tobacco Companies: They could argue that slashing nicotine levels could backfire. Their claim is, smokers will turn to black markets or smoke more to satisfy their cravings, which may lead to greater exposure to harmful substances.
Consumer Reluctance: History is proof to the instances of smokers being hesitant to embrace the low-nicotine products.
Political Hurdle: It may face political roadblocks, as under the Trump administration, plans to cut nicotine were shelved.
Advocates believe that ultralow-nicotine cigarettes could be a game-changer, comparing them to decaf coffee or non-alcoholic beer—products that reduce harm while offering a similar experience.
Some experts warn that a black market for traditional cigarettes could undermine these efforts. They also stress the need for safer alternatives, such as vaping products, to support smokers transitioning away from traditional cigarettes.
Credit: AI
Ischemic strokes are usually treated by removing the blood clot. But it may not be enough. New research has emerged, claiming that the brain’s own response to the stroke may keep causing damage even after the original blockage has been cleared.
A study published in the Proceedings of the National Academy of Sciences have found a process in which the body’s defence mechanism can backfire, producing tiny blood clots that damage brain tissue.
The findings may explain why two people with seemingly similar strokes can have completely different recoveries.
An ischemic stroke happens when a blood clot blocks a blood vessel supplying the brain. The severed oxygen supply can rapidly injure brain cells.
Doctors can restore the cerebral blood flow by using medicines to bust the blood clot or, in more severe cases, surgically removing the clot through a procedure called thrombectomy. But restoring blood flow does not necessarily mean the damage immediately stops.
The new research suggests that the immune system, which normally helps the body respond to injury, can become part of the problem.
Also read: Sweetener In Sugar-Free Gum Linked To 57% Higher Heart Attack And Stroke Risk: What Is Xylitol?
When a stroke occurs, the body's defence system springs into action to prevent the injury and begin the repair process as soon as possible. But, researchers found that this defensive response can also promote the formation of micro-clots.
Micro-clots are far smaller than the original clot that caused the stroke. Because of their size, they can obstruct tiny blood vessels that are even more difficult to detect or treat using conventional techniques to remove clots.
The result can be reduced blood flow and additional injury to brain tissue, even after the main artery has been reopened.
Also read: Vitamin D3 Outperforms D2 In Maintaining Muscle, Heart Function, Shows ICMR Study
The research offers one possible explanation for the wide differences seen in stroke recovery. Removing the major clot may restore circulation through the main blood vessel, but if microscopic vessels remain blocked, some areas of the brain may continue receiving inadequate blood supply and thus get damaged further
That could contribute to ongoing tissue damage and poorer neurological recovery, researchers suggest.
It also highlights why simply measuring whether the original artery that has been reopened may not tell the whole story of what is happening inside the brain.
The findings are still at the early research stage, so it does not mean that patients currently need a different treatment for stroke after thrombectomy.
But, understanding how these secondary micro-clots form could eventually open another avenue for treatment that could prevent further damage to the brain.
Instead of focusing only on removing the large clot that triggered the stroke, future treatment strategies could target the biological processes that cause these microscopic blockages to form.
Credit: American College of Cardiology Foundation and the American Heart Association
A new study found that nearly 8 out of 10, or 80%, of young adults in the US, with an average age of 23, had cardiovascular-kidney-metabolic (CKM) syndrome.
Published in Circulation: Population Health and Outcomes, the study found that these young adults had CKM syndrome at Stage 1, 2 or 3, meaning they had excess adiposity, metabolic risk factors and/or evidence of subclinical cardiovascular disease.
The study included 1,283 young adults from large US cities. About 21% had no identifiable CKM risk factors (Stage 0), while none were in Stage 4.
More advanced CKM stages were associated with early arterial injury, including thicker carotid artery walls, an early marker of atherosclerosis, even among people in their early 20s.
Researchers said the findings highlight the need to begin prevention earlier in life. They also suggested promoting the American Heart Association’s Life’s Essential 8 early in life to improve cardiovascular health.
Life’s Essential 8 focuses on
“The findings are important because they show that cardiovascular risk can begin building much earlier than we traditionally expect. We often associate heart disease with middle age or older adults, but risk factors such as excess weight, high blood pressure, abnormal cholesterol and elevated blood sugar can develop silently in young adults,” Dr. Gobu P, Senior Consultant Cardiology, Gleneagles Chennai, told HealthandMe.
Dr. Chetan Kumar H. B, Senior Consultant, Cardiology, Fortis Hospital, Bannerghatta Road, Bengaluru, added that heart, kidney and metabolic health issues can start much earlier than traditionally thought. While heart disease becomes more common with age, the risk factors that lead to it can begin developing in early adulthood.
The findings do not mean that these young adults already have heart disease. Rather, the association between advanced CKM risk and early arterial changes highlights the importance of identifying and addressing risk factors early.
Read More: Fifth Universal Definition of Myocardial Infarction: What the 3 New Heart Attack Categories Mean
Young adults do not necessarily need extensive cardiac investigations simply because of their age. However, those who are overweight, have high blood pressure, abnormal cholesterol, diabetes or a family history of premature heart disease should consider regular health checks.
“Monitoring blood pressure, blood sugar, cholesterol and maintaining a healthy weight can help identify risks early. Early intervention through lifestyle changes, and medication when required, can significantly reduce the chances of cardiovascular disease later in life,” Dr. Gobu said.
Dr. Chetan noted that unhealthy eating habits, lack of physical activity, obesity, high blood pressure, abnormal cholesterol and rising blood sugar levels are increasingly seen at younger ages. These problems can develop silently and gradually affect the heart, kidneys and blood vessels.
“Young adults should not wait until they are symptomatic to start paying attention to their health. Simple tests like blood pressure, blood sugar, cholesterol and weight can go a long way in identifying risks early, especially in those with a family history of diabetes, hypertension, kidney or heart disease," he told HealthandMe.
The experts stressed that the findings should be viewed as a call for prevention rather than alarm. Identifying and addressing risk factors early could help protect long-term heart, kidney and metabolic health.
Credit: X
Gone are the days when teeth brushing involved just a toothbrush and toothpaste. It seems that the future of ultimate oral health is here as a newly developed AI toothbrush lets you see parts of your mouth to see parts that you may miss.
The electric toothbrush with a built-in camera and machine-learning technology that watches the mouth while you brush. The device is designed to identify gaps between teeth in real time and direct a targeted stream of mouth rinse into those areas.
The technology is aimed at the spaces between teeth, one of the most easily missed parts of daily oral hygiene.
The toothbrush has a 100,000-pixel macro-lens camera built into the brush head. Its Gap Optical Targeting system analyses 28 images every second, using machine learning to detect, track and predict the position of gaps between teeth.
When it identifies a gap, the toothbrush can automatically trigger a precision conical jet of mouth rinse, directing up to 0.15ml of liquid between the teeth.
In other words, instead of simply brushing over the surfaces of the teeth, the device attempts to identify where cleaning is being missed and target those areas while you continue brushing.
The camera also streams live footage to a specifically designed app, allowing users to see their brushing technique and coverage.
Also read: Vitamin D3 Outperforms D2 In Maintaining Muscle, Heart Function, Shows ICMR Study
Brushing alone cannot adequately reach every tight space between teeth. Food particles and plaque can become trapped there, allowing bacteria to accumulate.
If plaque remains undisturbed, it can harden into tartar and contribute to gum irritation, bleeding gums, bad breath, and gum disease. Interdental cleaning, therefore, is an important part of oral hygiene alongside brushing. Rather than relying on people remembering to floss separately, the device combines brushing and targeted cleaning with a jet.
Dyson says its toothbrush, named Camerajet, has been clinically shown to improve gum health in two weeks when used with its low-foaming mouth rinse compared with a manual toothbrush.
It says its brushing system can remove up to 69% more plaque than leading electric toothbrushes. However, evidence is limited, so they should not be interpreted as proof that the device is superior to every existing electric toothbrush or professional dental care.
According to the The Guardian, the British Dental Association cautioned that expensive technology is not a replacement for maintaining consistent oral hygiene.
The more interesting feature of the toothbrush is that it can respond to what it sees. Most toothbrushes provide instructions about where and how long to brush.
The AI brush attempts to take that a step further by detecting areas that need attention and directing cleaning there in real time.
Additionally, unlike traditional water flossers that typically use a needle-shaped stream, this brush uses a broader, cone-shaped jet that sprays mouth rinse across a wider area between the teeth.
But even the smartest toothbrush cannot replace regular dental check-ups, professional cleaning when needed, or a consistent oral-care routine.
© $2026 Times Horizon Private Limited